Alexion Pharmaceuticals

Alexion Pharmaceuticals

World Rank (Aug-2026)
523
World Rank (Jan-05-2024)
523
World Rank (Jul-30-2023)
523
World Rank (Jan-07-2022)
523
Market Cap (Jan-07-2022)
39.000 Billion USD
World Rank (Jan-01-2021)
519
Market Cap (Jan-01-2021)
34.173 Billion USD
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
CEO
Ludwig N. Hantson
Chairman
David R. Brennan
Employee Count
3,837
Employee Count as of Date
As on May 2021
Headquarters City/State
Connecticut
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
6,070 Million USD
Annual Operating Income in USD
632 Million USD
Annual Net Income in USD
603 Million USD
Annual Results for Period Ending
For year ending December-2020
Total Assets in USD
18,103 Million USD
Total Liabilities in USD
6,452 Million USD
Total Equity in USD
11,651 Million USD
Balance Sheet for Period Ending
As of December-2020
Business Sector
Healthcare
Biotechnology
Pharmaceutical
HealthCare Products
Technology
Company Website
ALEXION PHARMACEUTICALS INC
Wikipedia
Wikipedia
Company Profile

Alexion Pharmaceuticals is USA based pharmaceutical company with headquarters is in Connecticut, USA.

Astrazeneca acquired Alexion Pharmaceuticals for 39 Billion USD.

Facts About Company

Astrazeneca company acquired Alexion Pharmaceuticals for 39 Billion USD in 2020.

Founded Year
1992
IPO Year
1996

Share